Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$49.88
-0.16-0.32%
Last update: Oct 20, 6:46 PM
$50.05
0.010.02%
CRISPR Therapeutics AG (CRSP) Stock Price, Quote, News & History
CRSPNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of CRISPR Therapeutics (NASDAQ:CRSP) through any online brokerage.
Other companies in CRISPR Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
CRISPR Therapeutics has a consensus price target of $71.48.
The stock price for CRISPR Therapeutics (NASDAQ: CRSP) is $50.05 last updated October 20, 2026 at 6:46 PM EDT.
There are no upcoming dividends for CRISPR Therapeutics.
CRISPR Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for CRISPR Therapeutics.
CRISPR Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
